DiaCarta's Multivariant COVID-19 Test Accurately Detects the Omicron Variant

/PRNewswire/ -- DiaCarta Inc., a precision molecular diagnostics company and leading developer of novel oncology tests using liquid biopsy announced today that...

Related Keywords

India ,Hong Kong ,United Kingdom ,Israel ,Botswana ,Brazil ,California ,United States ,South Africa ,Ram Vairavan ,Olipriya Das ,Aiguo Adam Zhang ,Molecular Clamping Technology ,Diacarta Inc ,World Health Organization ,Detection Test ,Delta Plus ,Senior Vice President ,Commercial Operations ,Next Generation Sequencing ,Madam Zhang ,Use Authorization ,Vitro Diagnostics ,Colorectal Cancer ,Vice President ,